Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are ...
In a letter to Bernie Sanders, Novo Nordisk said it only retains 60% of the list price of either Ozempic or Wegovy ...
Telehealth company Hims & Hers announced they will begin selling off-brand GLP-1 drugs similar to Ozempic and Wegovy at a ...
Public interest in weight loss drugs like Wegovy and Ozempic is surging, but national data on dispensing patterns in the United States is surprisingly scarce. Now, a national study from Michigan ...
Adults who were overweight or had obesity and took Wegovy (semaglutide) lost an average of 10 percent of their body weight — and kept it off — after four years on the drug. Semaglutide may ...
While the UK stock market is rising, the Diageo share price is falling. Here, Edward Sheldon looks at what’s going on with ...
The new generation of weight-loss drugs were initially developed to treat diabetes and work by mimicking a hormone that regulates insulin levels and appetite. When celebrities started shedding ...
It was ironic that the confession came midway through dinner. “I’ve started taking Ozempic,” my friend whispered in between small mouthfuls of the Thai green curry I’d just made for us.
Share on Pinterest A trio of new studies suggest that people who use GLP-1 drugs like Ozempic and Wegovy may be more likely to develop ‘stomach paralysis’ (gastroparesis). SeventyFour/Getty ...
Giving obese children semaglutide could reduce their risk by 90 per cent. It comes after Diabetes UK revealed obesity has ...
Appetite suppressing drugs are becoming a hot topic of conversation, with doctors now suggesting they could have important clinical benefits not just limited to weight loss. A new five-year study ...
Anti-obesity jabs could reduce the risk of heart attacks and strokes in people even if they fail to lose much weight, according to a study funded by a drug manufacturer. The five-year study ...